CL2014000717A1 - Compuestos derivados de 4h,6h-5-oxa-2,3,10b-triaza-benzo [e] azulenos, antagonistas del receptor v1a; proceso de obtencion; composicion farmaceutica que los contiene; uso en estados patologicos tales como dismenorrea, hipertension, cirrosis hepatica, sindrome nefrotico, ansiedad, entre otros. - Google Patents
Compuestos derivados de 4h,6h-5-oxa-2,3,10b-triaza-benzo [e] azulenos, antagonistas del receptor v1a; proceso de obtencion; composicion farmaceutica que los contiene; uso en estados patologicos tales como dismenorrea, hipertension, cirrosis hepatica, sindrome nefrotico, ansiedad, entre otros.Info
- Publication number
- CL2014000717A1 CL2014000717A1 CL2014000717A CL2014000717A CL2014000717A1 CL 2014000717 A1 CL2014000717 A1 CL 2014000717A1 CL 2014000717 A CL2014000717 A CL 2014000717A CL 2014000717 A CL2014000717 A CL 2014000717A CL 2014000717 A1 CL2014000717 A1 CL 2014000717A1
- Authority
- CL
- Chile
- Prior art keywords
- triaza
- dysmenorrhea
- oxa
- anxiety
- benzo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Pain & Pain Management (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11182796 | 2011-09-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2014000717A1 true CL2014000717A1 (es) | 2014-10-03 |
Family
ID=46881068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2014000717A CL2014000717A1 (es) | 2011-09-26 | 2014-03-24 | Compuestos derivados de 4h,6h-5-oxa-2,3,10b-triaza-benzo [e] azulenos, antagonistas del receptor v1a; proceso de obtencion; composicion farmaceutica que los contiene; uso en estados patologicos tales como dismenorrea, hipertension, cirrosis hepatica, sindrome nefrotico, ansiedad, entre otros. |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US8828989B2 (es) |
| EP (1) | EP2760871B1 (es) |
| JP (1) | JP5909554B2 (es) |
| KR (1) | KR101682777B1 (es) |
| CN (1) | CN103827121B (es) |
| AR (1) | AR087999A1 (es) |
| AU (1) | AU2012314593B2 (es) |
| BR (1) | BR112014006945A2 (es) |
| CA (1) | CA2844581A1 (es) |
| CL (1) | CL2014000717A1 (es) |
| CO (1) | CO6870036A2 (es) |
| CR (1) | CR20140092A (es) |
| EA (1) | EA024990B1 (es) |
| EC (1) | ECSP14013271A (es) |
| IN (1) | IN2014CN02169A (es) |
| MA (1) | MA35535B1 (es) |
| MX (1) | MX2014003643A (es) |
| PE (1) | PE20141397A1 (es) |
| SG (1) | SG2014010607A (es) |
| TW (1) | TWI553013B (es) |
| UA (1) | UA111623C2 (es) |
| WO (1) | WO2013045373A1 (es) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR200102069T2 (tr) | 1999-01-19 | 2001-11-21 | Ortho-Mcneil Pharmaceutical, Inc. | Vasopresin reseptörü antagonistleri olarak trisiklik benzodiazepinler. |
| US6765004B1 (en) | 1999-06-17 | 2004-07-20 | Ortho-Mcneil Pharmaceutical, Inc. | Indoloazepines as vasopressin receptor antagonists |
| GB0303852D0 (en) * | 2003-02-19 | 2003-03-26 | Pfizer Ltd | Triazole compounds useful in therapy |
| US7119088B2 (en) | 2003-02-19 | 2006-10-10 | Pfizer Inc. | Triazole compounds useful in therapy |
| GB0400700D0 (en) * | 2004-01-13 | 2004-02-18 | Pfizer Ltd | Compounds useful in therapy |
| CA2578370A1 (en) * | 2004-08-25 | 2006-03-02 | Pfizer Inc. | Triazolobenzodiazepines and their use as vasopressin antagonists |
| MX2011005119A (es) | 2008-11-18 | 2011-05-30 | Hoffmann La Roche | Alquilciclohexileteres de dihidrotetraazabenzoazulenos. |
| BRPI0922303B1 (pt) | 2008-11-28 | 2019-11-12 | Hoffmann La Roche | arilciclo-hexiléteres de di-hidrotetra-azabenzoazulenos, seu processo de preparação, composição farmacêutica que os compreende e uso |
-
2012
- 2012-08-23 US US13/592,493 patent/US8828989B2/en active Active
- 2012-09-24 CN CN201280046689.0A patent/CN103827121B/zh active Active
- 2012-09-24 UA UAA201403611A patent/UA111623C2/uk unknown
- 2012-09-24 WO PCT/EP2012/068721 patent/WO2013045373A1/en active Application Filing
- 2012-09-24 SG SG2014010607A patent/SG2014010607A/en unknown
- 2012-09-24 EA EA201490558A patent/EA024990B1/ru not_active IP Right Cessation
- 2012-09-24 MX MX2014003643A patent/MX2014003643A/es unknown
- 2012-09-24 IN IN2169CHN2014 patent/IN2014CN02169A/en unknown
- 2012-09-24 PE PE2014000394A patent/PE20141397A1/es not_active Application Discontinuation
- 2012-09-24 EP EP12761740.5A patent/EP2760871B1/en active Active
- 2012-09-24 BR BR112014006945A patent/BR112014006945A2/pt not_active IP Right Cessation
- 2012-09-24 AU AU2012314593A patent/AU2012314593B2/en not_active Ceased
- 2012-09-24 KR KR1020147010783A patent/KR101682777B1/ko active IP Right Grant
- 2012-09-24 CA CA2844581A patent/CA2844581A1/en not_active Abandoned
- 2012-09-24 JP JP2014532331A patent/JP5909554B2/ja active Active
- 2012-09-25 AR ARP120103514A patent/AR087999A1/es unknown
- 2012-09-25 TW TW101135168A patent/TWI553013B/zh not_active IP Right Cessation
-
2014
- 2014-01-31 CO CO14020668A patent/CO6870036A2/es not_active Application Discontinuation
- 2014-02-26 CR CR20140092A patent/CR20140092A/es unknown
- 2014-03-24 CL CL2014000717A patent/CL2014000717A1/es unknown
- 2014-03-26 EC ECSP14013271 patent/ECSP14013271A/es unknown
- 2014-04-15 MA MA36919A patent/MA35535B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA201490558A1 (ru) | 2014-06-30 |
| CA2844581A1 (en) | 2013-04-04 |
| AR087999A1 (es) | 2014-04-30 |
| BR112014006945A2 (pt) | 2017-04-04 |
| KR20140079790A (ko) | 2014-06-27 |
| JP2014527993A (ja) | 2014-10-23 |
| CR20140092A (es) | 2014-03-20 |
| EP2760871B1 (en) | 2018-07-18 |
| CN103827121B (zh) | 2016-08-03 |
| WO2013045373A1 (en) | 2013-04-04 |
| PE20141397A1 (es) | 2014-10-13 |
| IN2014CN02169A (es) | 2015-05-29 |
| NZ620653A (en) | 2016-03-31 |
| AU2012314593A8 (en) | 2014-03-27 |
| MX2014003643A (es) | 2014-04-30 |
| SG2014010607A (en) | 2014-05-29 |
| CN103827121A (zh) | 2014-05-28 |
| US20130079333A1 (en) | 2013-03-28 |
| EP2760871A1 (en) | 2014-08-06 |
| KR101682777B1 (ko) | 2016-12-05 |
| CO6870036A2 (es) | 2014-02-20 |
| US8828989B2 (en) | 2014-09-09 |
| TW201315737A (zh) | 2013-04-16 |
| JP5909554B2 (ja) | 2016-04-26 |
| AU2012314593A1 (en) | 2014-02-20 |
| TWI553013B (zh) | 2016-10-11 |
| UA111623C2 (uk) | 2016-05-25 |
| ECSP14013271A (es) | 2014-05-31 |
| MA35535B1 (fr) | 2014-10-02 |
| AU2012314593B2 (en) | 2016-09-29 |
| EA024990B1 (ru) | 2016-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP14004976A (es) | Anticuerpos anti-il-36r | |
| ECSP12012221A (es) | Anticuerpos anti-cd40 | |
| DOP2014000093A (es) | Compuestos con actividad nematicida | |
| CL2015001570A1 (es) | Método en un solo recipiente para la síntesis de cu-ssz-13, el compuesto obtenido por medio del método y uso del mismo. | |
| BR112013033804A2 (pt) | re-roteamento rápido de mpls com o uso de ldp (ldp-frr) | |
| CO6321189A2 (es) | Compuestos de tiazol y oxazol de bencen-sulfonamida | |
| EA201401054A1 (ru) | N-циклиламиды в качестве нематоцидов | |
| ECSP14013327A (es) | Compuestos con actividad nematicida | |
| EA201590887A1 (ru) | Композиция | |
| UY34765A (es) | Compuestos novedosos. | |
| UY34697A (es) | Métodos para preparar análogos de nucleótidos | |
| EA201492223A1 (ru) | Новые диазаспироциклоалканы и азаспироциклоалканы | |
| UY34418A (es) | Compuestos derivados de la piridopiracina, su preparación, composiciones que los contienen y su uso en terapia | |
| JP2012081521A5 (es) | ||
| ZA201400752B (en) | Eutectic mixture for pulmonary administration | |
| DK2817382T4 (da) | Sammensætning omfattende en alkoxyleret aminforbindelse og en carboxylsyreforbindelse, anvendelse deraf i vand-i-olie emulsioner og fremgangsmåde til anvendelse af sammensætningen som eller som en del af en borevæske | |
| BR112013014854A2 (pt) | compostos de n-(1h-indazol-4-il)midazo [1,2-a] piridina-3-carboxamida substituídos como inibidores de tirosina quinase de receptor tipo iii | |
| EA201490567A1 (ru) | Новые бициклические производные дигидрохинолин-2-она | |
| UY34467A (es) | Procedimiento para la preparación de 5-fluoro-1h-pirazolopiridinas sustituidas | |
| CR20130671A (es) | Antagonistas de trpv4 | |
| DK2557606T3 (da) | Luminescent solkoncentrator omfattende disubstituerede benzothiadiazolforbindelser | |
| DK2582673T3 (da) | Fremgangsmåde til fremstilling af 2,2-difluorethylamin-derivater ved hjælp af alkylering med 2,2-difluor-1-halogenethaner | |
| CO7020909A2 (es) | Compuesto tricíclicos, composiciones que los comprenden y uso de los mismos | |
| UY34355A (es) | Composición ecológica para curtido | |
| CL2016002240A1 (es) | Derivados de piperidina como antagonista de receptores de orexina |